Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy, August 26, 2009, Shuldiner et al. 302 (8): 849 — JAMA

Web Page

Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy, August 26, 2009, Shuldiner et al. 302 (8): 849 — JAMA

N/ACitations

1Readers

Cite

CITATION STYLE

APA

Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy, August 26, 2009, Shuldiner et al. 302 (8): 849 — JAMA. (n.d.). Retrieved from http://jama.ama-assn.org/content/302/8/849.long

Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy, August 26, 2009, Shuldiner et al. 302 (8): 849 — JAMA

Cite

Register to see more suggestions